Filing Details

Accession Number:
0001179110-14-005624
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-03-20 18:21:20
Reporting Period:
2014-03-19
Filing Date:
2014-03-20
Accepted Time:
2014-03-20 18:21:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070081 Ptc Therapeutics Inc. PTCT Pharmaceutical Preparations (2834) 043416587
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1578850 Gregory Neil Almstead C/O Ptc Therapeutics, Inc.
100 Corporate Court
South Plainfield NJ 07080
Senior Vp, Research And Cmc No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-03-19 10,359 $31.90 30,381 No 4 S Direct
Common Stock Disposition 2014-03-19 500 $32.21 29,881 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,549 Indirect By spouse
Footnotes
  1. The sale transactions reported in this Form 4 were effected pursuant to a written Rule 10b5-1 plan adopted by the reporting person on August 16, 2013 for the primary purpose of covering tax obligations associated with a restricted stock vesting event.
  2. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $31.18 to $32.15 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
  3. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $32.19 to $32.27 per share. The reporting person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.